Shao Yebo, Zhou Yuhong, Hou Yingyong, He Junyi, Hu Lei, Zhang Yong, Jiang Ying, Lu Weiqi, Liu Houbao
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Cell Biochem Biophys. 2014 Nov;70(2):747-58. doi: 10.1007/s12013-014-9976-6.
SLIT, a secretory glycoprotein, and its receptor roundabout (ROBO) are expressed in several types of cancer and have been implicated in tumor angiogenesis. The purpose of this study was to determine the prognostic implications of SLIT and ROBO1 expression and their association with clinicopathologic characteristics in gallbladder cancer. A retrospective analysis of 109 consecutive patients who underwent primary gallbladder cancer resection was conducted. Univariate and multivariate models were used to analyze the effect of clinicopathologic factors on survival. Expression of SLIT and ROBO1 was evaluated by immunohistochemistry, and their association with clinicopathologic characteristics was analyzed using mean testing. Multivariate linear regression analysis was also applied to investigate the independent predictors of ROBO1 expression. Seventy-five patients were included in the post-resection survival analysis, with 1-year and 3-year overall survival rates of 60 and 40 %, respectively. Univariate analysis revealed that pN classification, pT classification, pM classification, liver involvement, perineural invasion, TNM staging, Nevin staging, and microscopic resection margins affect prognosis. Multivariate analysis confirmed that pN classification, liver involvement, and perineural invasion are independent prognostic factors. In the mean tests of 109 cases, the mean difference of SLIT immunoreactivity was significant according to the presence of gallstones (P = 0.003) and liver involvement (P = 0.005), while the mean difference of ROBO1 immunoreactivity was significant according to liver involvement (P < 0.001), TNM staging (P < 0.001), and Nevin staging (P < 0.001). Multivariate analysis of ROBO1 immunoreactivity showed that SLIT immunoreactivity and TNM stage (adjusted R (2) = 0.203) or SLIT immunoreactivity and Nevin stage (adjusted R (2) = 0.195) were independent predictors of ROBO1 expression. pN classification, liver involvement, perineural invasion, and pathologic stage are significant prognostic factors for gallbladder cancer survival. SLIT expression is associated with cholelithiasis and liver involvement, and ROBO1 expression is associated with liver involvement and pathologic stage. In addition, SLIT expression and pathologic stage predict ROBO1 expression independently.
分泌性糖蛋白SLIT及其受体Roundabout(ROBO)在多种癌症类型中均有表达,并与肿瘤血管生成有关。本研究旨在确定SLIT和ROBO1表达的预后意义及其与胆囊癌临床病理特征的关系。对109例连续接受原发性胆囊癌切除术的患者进行了回顾性分析。采用单因素和多因素模型分析临床病理因素对生存的影响。通过免疫组织化学评估SLIT和ROBO1的表达,并使用均值检验分析它们与临床病理特征的关系。还应用多因素线性回归分析来研究ROBO1表达的独立预测因素。75例患者纳入切除术后生存分析,1年和3年总生存率分别为60%和40%。单因素分析显示,pN分类、pT分类、pM分类、肝脏受累、神经周围侵犯、TNM分期、Nevin分期和显微镜下切缘影响预后。多因素分析证实,pN分类、肝脏受累和神经周围侵犯是独立的预后因素。在对109例病例的均值检验中,根据胆结石的存在(P = 0.003)和肝脏受累情况(P = 0.005),SLIT免疫反应性的均值差异具有显著性,而根据肝脏受累情况(P < 0.001)、TNM分期(P < 0.001)和Nevin分期(P < 0.001),ROBO1免疫反应性的均值差异具有显著性。对ROBO1免疫反应性的多因素分析表明,SLIT免疫反应性和TNM分期(调整后R(2) = 0.203)或SLIT免疫反应性和Nevin分期(调整后R(2) = 0.195)是ROBO1表达的独立预测因素。pN分类、肝脏受累、神经周围侵犯和病理分期是胆囊癌生存的重要预后因素。SLIT表达与胆石症和肝脏受累有关,ROBO1表达与肝脏受累和病理分期有关。此外,SLIT表达和病理分期可独立预测ROBO1表达。